Trial failures can arise from factors such as failing to maintain suitable protocols, being unable to follow FDA guidance, complex procedures for participating patients, slow recruitment, lack of efficacy, safety issues, and/or insufficient funding to complete a trial. BBCR experts provide an understanding of the reasons a trial failed and offer insights to create and execute successful clinical trial management protocols and CRO management.
– Boston Biotech Clinical Research (BBCR). Strategic Clinical Innovation Experts. Rare Disease, Clinical Trials, Clinical Research, & Biologics. We work with biotech, pharmaceutical, and device companies to develop clinical/regulatory road-maps consisting with simplified clinical programs, streamlined protocols, and cost-effective clinical trials. Our experienced team provides innovative strategies that meet your goals.
by Boston Biotech Clinical Research | May 16, 2023 | Company News, Trial Management
Trial Management that addresses risks
The experienced trial management address risks such as:
- Scarce enrollment
- Multiple protocol amendments
- Poor patient retention
- Poor data quality
- Prolonged trial completion timeline
- Poor safety monitor
Learn More
Specializing in rare disease, Boston Biotech Clinical Research works with biotech, pharmaceutical, device companies and investors to streamline the clinical trial process. Our experienced team helps each client reach their specific goals by customizing a clinical and regulatory road map of simplified programs and streamlined protocols to meet our clients’ requirements.
Tags: 